Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions.
about
Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitorInter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.Post-processing correction of magnetization transfer effects in FENSI perfusion MRI data.DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibilityAssessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data.Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imagingThe role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancerQuantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validationStatistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims.A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls.Clinical imaging of tumor angiogenesis.Advanced MR techniques in multicenter clinical trials.Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.Assessment of pharmacokinetics for microvessel proliferation by DCE-MRI for early detection of physeal bone bridge formation in an animal model.Reference region-based pharmacokinetic modeling in quantitative dynamic contract-enhanced MRI allows robust treatment monitoring in a rat liver tumor model despite cardiovascular changes.Distribution of Intravascular and Extravascular Extracellular Volume Fractions by Total Area under Curve for Neovascularization Assessment by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.Effects of flip angle uncertainty and noise on the accuracy of DCE-MRI metrics: comparison between standard concentration-based and signal difference methods.A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors.Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.TumourMetrics: a comprehensive clinical solution for the standardization of DCE-MRI analysis in research and routine use.Diffusion-weighted (DW) MRI in lung cancers: ADC test-retest repeatability.Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.Phase-based vascular input function: Improved quantitative DCE-MRI of atherosclerotic plaques.Phase-based arterial input functions in humans applied to dynamic contrast-enhanced MRI: potential usefulness and limitations.Observer Variability in CT Perfusion Parameters in Primary and Metastatic Tumors in the Lung.
P2860
Q24594930-D691EE84-AAA9-445B-A43C-6907221D6866Q30581552-60B9DE16-236D-4971-B20D-CB888D491B36Q33699102-86CDCC4D-B0B5-4EC3-A859-ECDA81EE9359Q33759248-64CAAC03-EF6B-458E-A434-5A486892797EQ33888366-118C9CCD-3C61-46AE-98DB-56AA74AB78D5Q34269947-261007AF-FD9A-4591-A833-2D0F8E46F6CDQ34754745-8D8A2632-DE2A-4CF5-AD92-E604A775DF9AQ34776912-CA8B1C45-AD30-49D5-85A8-E4CB3E7125E0Q35738413-7A2ABF72-93B2-4FB2-8EC3-E7B43DA99C0AQ36797014-8F003C0E-832B-4F01-B35E-3CD8C182CA36Q37662706-AD0BC0C1-2918-40AA-89A6-9C0D017706E9Q37721529-F3A27F5C-CA73-43C8-B933-EF09BE0F52DEQ38059503-40CE91E2-11A5-49D3-984B-7CE765DED8E8Q38092796-FFCCA5EB-F109-4A1D-A4A4-270BEDA2C67DQ38464689-0F1A823D-93D4-43C3-B1B6-249ADA708D2BQ38865642-901F3D2C-CA50-4E11-BAA9-6AB2123BCC7FQ39651262-2DAB10D8-92BA-4ED8-861F-A3AF26FDA45CQ42931964-14EFA87E-3501-4EC2-8D3E-F812CE2F28DCQ43067918-82CFF2E4-27C3-4E2C-AB13-8536BF3C064BQ43898245-1F053FA4-1C88-460C-B6C4-C0DD604E44C7Q47094309-7545ABC9-44E2-45FC-81B0-AF758CCE2BDBQ47104951-3E63EDD9-9246-4C1C-966B-7083ADF75206Q47923488-F282EF62-BC1B-4D79-905D-466C3720295AQ48541561-47B38FB7-CBFA-4E40-AAE8-95C72ADD3C92Q50872729-A35B8141-2624-4434-A3B2-825B9FE919BEQ51563281-0D391E12-09D4-4152-8F94-89CA30578964Q55030577-EE03063C-9C10-478F-AEF7-8658E644002E
P2860
Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Scan-rescan variability in per ...... ived arterial input functions.
@ast
Scan-rescan variability in per ...... ived arterial input functions.
@en
type
label
Scan-rescan variability in per ...... ived arterial input functions.
@ast
Scan-rescan variability in per ...... ived arterial input functions.
@en
prefLabel
Scan-rescan variability in per ...... ived arterial input functions.
@ast
Scan-rescan variability in per ...... ived arterial input functions.
@en
P2093
P356
P1476
Scan-rescan variability in per ...... ived arterial input functions.
@en
P2093
David Raunig
Edward Ashton
Fredrick Kelcz
Jeffrey Evelhoch
Teresa McShane
P304
P356
10.1002/JMRI.21472
P577
2008-09-01T00:00:00Z